Key result
Antithrombotics in AF post-ACS or PCI require careful balancing of ischemic and bleeding risks.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Lópes et al. (2019) studied this question. Antithrombotic therapy for patients with atrial fibrillation after acute coronary syndrome or percutaneous coronary intervention requires careful balancing of ischemic and bleeding risks.
Synapse has enriched 10 related papers. Consider them for comparative context: